Cytotoxic T-lymphocyte protein 4
| Pathway Name | Organism |
|---|---|
| CTLA4 inhibitory signaling | Homo sapiens |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:2048 | autoimmune hepatitis | |
| DOID:2377 | multiple sclerosis | |
| DOID:2513 | basal cell carcinoma | |
| DOID:2841 | asthma | |
| DOID:3083 | chronic obstructive pulmonary disease | |
| DOID:3310 | atopic dermatitis | |
| DOID:4450 | renal cell carcinoma | |
| DOID:4780 | anti-basement membrane glomerulonephritis | |
| DOID:557 | kidney disease | |
| DOID:5844 | myocardial infarction |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025